Literature DB >> 19279001

Retinoblastoma/p107/p130 pocket proteins: protein dynamics and interactions with target gene promoters.

Kristy R Stengel1, Chellappagounder Thangavel, David A Solomon, Steve P Angus, Yi Zheng, Erik S Knudsen.   

Abstract

The retinoblastoma (RB) tumor suppressor and its family members, p107 and p130, function by repressing E2F transcription factor activity to limit the expression of genes required for cell cycle progression. Traditionally, it is thought that the RB family proteins repress E2F target gene expression through complexing with E2F at gene promoters. However, whereas chromatin immunoprecipitation experiments have demonstrated p107 and p130 at E2F-responsive promoters, RB chromatin association has not been reliably observed. Here we used green fluorescent protein-tagged proteins to rigorously explore the mechanism of RB-mediated transcriptional repression relative to its p107 and p130 family members. The use of live cell fluorescent imaging demonstrated that RB, p107, and p130 exhibit similar nuclear dynamics. Although these findings suggest a similar engagement with nuclear structures, chromatin immunoprecipitation approaches with multiple independent antibodies failed to detect the association of RB with target gene promoters. However, by employing antibodies directed against green fluorescent protein, we could utilize the same antibody to assess RB, p107, and p130 engagement. This approach demonstrated RB association with target gene promoters in a fashion analogous to p107 and p130. Extension of this technology demonstrated that direct RB phosphorylation disrupts promoter association to regulate transcription. Thus, RB is associated with promoters in a manner similar to p107/p130 and that association is modulated by phosphorylation during cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19279001      PMCID: PMC2740551          DOI: 10.1074/jbc.M808740200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Pocket proteins and cell cycle control.

Authors:  David Cobrinik
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

2.  Pocket protein complexes are recruited to distinct targets in quiescent and proliferating cells.

Authors:  Egle Balciunaite; Alexander Spektor; Nathan H Lents; Hugh Cam; Hein Te Riele; Anthony Scime; Michael A Rudnicki; Richard Young; Brian David Dynlacht
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 3.  Life and death decisions by the E2F transcription factors.

Authors:  Phillip J Iaquinta; Jacqueline A Lees
Journal:  Curr Opin Cell Biol       Date:  2007-11-26       Impact factor: 8.382

Review 4.  E2F-associated chromatin modifiers and cell cycle control.

Authors:  Alexandre Blais; Brian D Dynlacht
Journal:  Curr Opin Cell Biol       Date:  2007-11-19       Impact factor: 8.382

5.  SWI/SNF activity is required for the repression of deoxyribonucleotide triphosphate metabolic enzymes via the recruitment of mSin3B.

Authors:  Ranjaka W Gunawardena; Sejal R Fox; Hasan Siddiqui; Erik S Knudsen
Journal:  J Biol Chem       Date:  2007-05-17       Impact factor: 5.157

6.  Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation.

Authors:  Gregory David; Kathryn B Grandinetti; Patricia M Finnerty; Natalie Simpson; Gerald C Chu; Ronald A Depinho
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

7.  Binding of the retinoblastoma protein is not the determinant for stable repression of some E2F-regulated promoters in muscle cells.

Authors:  Marie Vandromme; Catherine Chailleux; Fabrice Escaffit; Didier Trouche
Journal:  Mol Cancer Res       Date:  2008-02-22       Impact factor: 5.852

8.  Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function.

Authors:  M P Markey; J Bergseid; E E Bosco; K Stengel; H Xu; C N Mayhew; S J Schwemberger; W A Braden; Y Jiang; G F Babcock; A G Jegga; B J Aronow; M F Reed; J Y J Wang; E S Knudsen
Journal:  Oncogene       Date:  2007-04-23       Impact factor: 9.867

9.  Mammalian Mip/LIN-9 interacts with either the p107, p130/E2F4 repressor complex or B-Myb in a cell cycle-phase-dependent context distinct from the Drosophila dREAM complex.

Authors:  M Pilkinton; R Sandoval; O R Colamonici
Journal:  Oncogene       Date:  2007-06-11       Impact factor: 9.867

10.  LINC, a human complex that is related to pRB-containing complexes in invertebrates regulates the expression of G2/M genes.

Authors:  Fabienne Schmit; Michael Korenjak; Mirijam Mannefeld; Kathrin Schmitt; Claudia Franke; Björn von Eyss; Sladjana Gagrica; Frank Hänel; Alexander Brehm; Stefan Gaubatz
Journal:  Cell Cycle       Date:  2007-05-25       Impact factor: 4.534

View more
  19 in total

1.  The Evolutionarily Conserved C-terminal Domains in the Mammalian Retinoblastoma Tumor Suppressor Family Serve as Dual Regulators of Protein Stability and Transcriptional Potency.

Authors:  Satyaki Sengupta; Raj Lingnurkar; Timothy S Carey; Monica Pomaville; Parimal Kar; Michael Feig; Catherine A Wilson; Jason G Knott; David N Arnosti; R William Henry
Journal:  J Biol Chem       Date:  2015-04-22       Impact factor: 5.157

2.  What's so special about RB?

Authors:  Christin E Burd; Norman E Sharpless
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

3.  Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer.

Authors:  Chellappagounder Thangavel; Jeffry L Dean; Adam Ertel; Karen E Knudsen; C Marcelo Aldaz; Agnieszka K Witkiewicz; Robert Clarke; Erik S Knudsen
Journal:  Endocr Relat Cancer       Date:  2011-04-28       Impact factor: 5.678

4.  Construction of a dual affinity tagged allele of the Rb1 tumor suppressor gene in the mouse.

Authors:  Hai Xiao; Xiaojing Zhang; David W Goodrich
Journal:  Genesis       Date:  2010-02       Impact factor: 2.487

5.  RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control.

Authors:  Ryan J Bourgo; Chellappagounder Thangavel; Adam Ertel; Jacqueline Bergseid; A Kathleen McClendon; Ludwig Wilkens; Agnieszka K Witkiewicz; Jean Y J Wang; Erik S Knudsen
Journal:  Mol Cell       Date:  2011-08-19       Impact factor: 17.970

Review 6.  RNA polymerase III repression by the retinoblastoma tumor suppressor protein.

Authors:  Alison Gjidoda; R William Henry
Journal:  Biochim Biophys Acta       Date:  2012-10-12

7.  E2F-1 has dual roles depending on the cell cycle.

Authors:  Fikret Sahin; Todd L Sladek
Journal:  Int J Biol Sci       Date:  2010-03-03       Impact factor: 6.580

8.  Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.

Authors:  Deborah L Burkhart; Stacey E Wirt; Anne-Flore Zmoos; Michael S Kareta; Julien Sage
Journal:  PLoS Genet       Date:  2010-06-24       Impact factor: 5.917

9.  E2F-1 binding affinity for pRb is not the only determinant of the E2F-1 activity.

Authors:  Fikret Sahin; Todd L Sladek
Journal:  Int J Biol Sci       Date:  2010-07-04       Impact factor: 6.580

10.  Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells.

Authors:  George Notas; Marilena Kampa; Vassiliki Pelekanou; Maria Troullinaki; Yves Jacquot; Guy Leclercq; Elias Castanas
Journal:  Mol Oncol       Date:  2013-02-20       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.